Straits Times Index
3,204.82 +2.01 (+0.06%) S&P 500
4,320.06 -9.94 (-0.23%) Dow
33,963.84 -106.56 (-0.31%) Nasdaq
13,211.81 -12.19 (-0.09%) Bitcoin USD
26,495.36 -80.44 (-0.30%) CMC Crypto 200
565.87 -2.18 (-0.38%)
ORGO Oct 2023 2.500 call
| Previous close | 0.2000 |
| Open | 0.2000 |
| Bid | 0.0000 |
| Ask | 0.2500 |
| Strike | 2.50 |
| Expiry date | 2023-10-20 |
| Day's range | 0.2000 - 0.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 410 |
Motley FoolWhy Shares of Organogenesis Holdings Are Dropping Thursday
Shares of Organogenesis Holdings (NASDAQ: ORGO) were down more than 19% as of 11 a.m. on Thursday after the company announced second-quarter earnings and withdrew annual guidance after the markets closed on Wednesday. Organogenesis is a healthcare company that makes advanced care products for the wound-healing process. The company operates in two segments, Advanced Wound Care and Surgical & Sports Medicine, and both saw declines.
Motley FoolOrganogenesis (ORGO) Q2 2023 Earnings Call Transcript
ORGO earnings call for the period ending June 30, 2023.
Motley FoolWhy Shares of Organogenesis Climbed Wednesday
Shares of Organogenesis (NASDAQ: ORGO) were up 15.4% Wednesday afternoon after being up as much as 21.2% Wednesday morning. The healthcare company sells advanced wound care products for surgical and sports medicine applications. Integra LifeSciences said on Tuesday that it was doing a voluntary recall of products, which could be worth as much as $60 million if the recall lasts all of 2023.
